Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 2
- 4
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Mutational landscape of gray zone lymphomaBlood, 2021, 137 (13), pp.1765-1776. ⟨10.1182/blood.2020007507⟩
Journal articles
hal-03257279v1
|
||
|
New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels (vol 7, 15126, 2016)Scientific Reports, 2018, 8, ⟨10.1038/s41598-018-36812-3⟩
Journal articles
hal-02619813v1
|
||
|
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centersAmerican Journal of Hematology, 2018, 93 (8), pp.1042-1049. ⟨10.1002/ajh.25154⟩
Journal articles
hal-02050402v1
|
||
In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort studyBritish Journal of Haematology, 2019, 188 (3), pp.413-423. ⟨10.1111/bjh.16176⟩
Journal articles
hal-02478970v1
|